Frozen tumors, clearer vision? scientists dig into 20 years of eye records
NCT ID NCT04458935
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at 20 years of medical records from 25 people who had a freezing treatment (cryotherapy) for retinal hemangioblastoma, a rare eye tumor often linked to von Hippel-Lindau disease. Researchers want to see how well the treatment controlled the tumors and affected vision. No new participants are needed—only existing data is reviewed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINAL HEMANGIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Eye Institute (NEI)
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists track hidden brain tumors in children with rare genetic condition
- Can a Stress-Busting program help VHL patients cope better?
- New PET scan agent aims to sharply detect multiple cancers
- Belzutifan extension trial aims to extend lives in VHL and advanced cancer
- New registry aims to unlock secrets of rare diseases
- VHL pancreatic tumors under the microscope: new scan tested